Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Yaiza N????ez-??lvarez
Affiliation
Institut d'Investigacio Biomedica Sant Pau (IIB SANT PAU)
ORCID
Career Start Year
2014
Papers
17
H Index
10
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36986589
T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo.
Pharmaceutics
2023
36986589
T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo.
Pharmaceutics
2023
34847435
A multivalent Ara-C-prodrug nanoconjugate achieves selective ablation of leukemic cells in an acute myeloid leukemia mouse model.
Biomaterials
2022
35421785
A diphtheria toxin-based nanoparticle achieves specific cytotoxic effect on CXCR4<sup>+</sup> lymphoma cells without toxicity in immunocompromised and immunocompetent mice.
Biomed Pharmacother
2022
33891374
HDAC11: a multifaceted histone deacetylase with proficient fatty deacylase activity and its roles in physiological processes.
FEBS J
2022
34847435
A multivalent Ara-C-prodrug nanoconjugate achieves selective ablation of leukemic cells in an acute myeloid leukemia mouse model.
Biomaterials
2022
35172149
Histone marks regulate the epithelial-to-mesenchymal transition via alternative splicing.
Cell Rep
2022
35057088
Time-Prolonged Release of Tumor-Targeted Protein-MMAE Nanoconjugates from Implantable Hybrid Materials.
Pharmaceutics
2022
35421785
A diphtheria toxin-based nanoparticle achieves specific cytotoxic effect on CXCR4<sup>+</sup> lymphoma cells without toxicity in immunocompromised and immunocompetent mice.
Biomed Pharmacother
2022
33891374
HDAC11: a multifaceted histone deacetylase with proficient fatty deacylase activity and its roles in physiological processes.
FEBS J
2022
35057088
Time-Prolonged Release of Tumor-Targeted Protein-MMAE Nanoconjugates from Implantable Hybrid Materials.
Pharmaceutics
2022
35172149
Histone marks regulate the epithelial-to-mesenchymal transition via alternative splicing.
Cell Rep
2022
32563202
HDAC11 is a novel regulator of fatty acid oxidative metabolism in skeletal muscle.
FEBS J
2021
34004204
Antineoplastic effect of a diphtheria toxin-based nanoparticle targeting acute myeloid leukemia cells overexpressing CXCR4.
J Control Release
2021
33716502
Specific Cytotoxic Effect of an Auristatin Nanoconjugate Towards CXCR4<sup>+</sup> Diffuse Large B-Cell Lymphoma Cells.
Int J Nanomedicine
2021
32602219
Loss of HDAC11 accelerates skeletal muscle regeneration in mice.
FEBS J
2021
32563202
HDAC11 is a novel regulator of fatty acid oxidative metabolism in skeletal muscle.
FEBS J
2021
33716502
Specific Cytotoxic Effect of an Auristatin Nanoconjugate Towards CXCR4<sup>+</sup> Diffuse Large B-Cell Lymphoma Cells.
Int J Nanomedicine
2021
34004204
Antineoplastic effect of a diphtheria toxin-based nanoparticle targeting acute myeloid leukemia cells overexpressing CXCR4.
J Control Release
2021
32602219
Loss of HDAC11 accelerates skeletal muscle regeneration in mice.
FEBS J
2021
30262812
Adipose tissue mitochondrial dysfunction in human obesity is linked to a specific DNA methylation signature in adipose-derived stem cells.
Int J Obes (Lond)
2019
30262812
Adipose tissue mitochondrial dysfunction in human obesity is linked to a specific DNA methylation signature in adipose-derived stem cells.
Int J Obes (Lond)
2019
28518147
Survivin, a key player in cancer progression, increases in obesity and protects adipose tissue stem cells from apoptosis.
Cell Death Dis
2017
28518147
Survivin, a key player in cancer progression, increases in obesity and protects adipose tissue stem cells from apoptosis.
Cell Death Dis
2017
28262839
Loss of the EPH receptor B6 contributes to colorectal cancer metastasis.
Sci Rep
2017
28262839
Loss of the EPH receptor B6 contributes to colorectal cancer metastasis.
Sci Rep
2017
27416614
DNA methylation dynamics in cellular commitment and differentiation.
Brief Funct Genomics
2016
27416614
DNA methylation dynamics in cellular commitment and differentiation.
Brief Funct Genomics
2016
24838345
Genetic and epigenetic determinants of low dysferlin expression in monocytes.
Hum Mutat
2014
25030697
Lineage of origin in rhabdomyosarcoma informs pharmacological response.
Genes Dev
2014
25313138
Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth.
Oncotarget
2014
24838345
Genetic and epigenetic determinants of low dysferlin expression in monocytes.
Hum Mutat
2014
25030697
Lineage of origin in rhabdomyosarcoma informs pharmacological response.
Genes Dev
2014
25313138
Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth.
Oncotarget
2014
1 - 34 of 34
Column Actions
Search
Recommended Authors
Mahmoud A Bassal
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year
2015
Number of shared co-authors
0
Tuo Zhang
Weill Cornell Medical College.
Career Start Year
2013
Number of shared co-authors
1
Xiongjun Wang
Guangzhou University
Career Start Year
2013
Number of shared co-authors
0
Yibu Chen
USC Libraries Bioinformatic Services of the University of Southern California
Career Start Year
2012
Number of shared co-authors
0
Fei Li
Shanghai Pulmonary Hospital, Tongji University School of Medicine
Career Start Year
2010
Number of shared co-authors
0
Rahul K Kollipara
McDermott Center for Human Growth and Development.
Career Start Year
2010
Number of shared co-authors
0
Daniel D'Andrea
Nottingham Trent University
Career Start Year
2010
Number of shared co-authors
0
Huiyuan Zhang
Texas Children's Cancer Center
Career Start Year
2010
Number of shared co-authors
0
Hua Yu
Guangzhou University
Career Start Year
2009
Number of shared co-authors
0
Jianying Zhang
City of Hope National Medical Center
Career Start Year
2009
Number of shared co-authors
0
Yang Chen
The University of Texas MD Anderson Cancer Center
Career Start Year
2008
Number of shared co-authors
0
Young K Song
National Cancer Institute, National Institutes of Health
Career Start Year
2007
Number of shared co-authors
5
Nan Zhu
Shanghai General Hospital, Shanghai Jiaotong University
Career Start Year
2007
Number of shared co-authors
0
Min Luo
Institute of Biomedical Science and Children's Hospital, Fudan University
Career Start Year
2006
Number of shared co-authors
0
Yue Lu
The University of Texas MD Anderson Cancer Center
Career Start Year
2006
Number of shared co-authors
0
Maggie Cam
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
2005
Number of shared co-authors
1
Theodore P Braun
Oregon Health & Science University
Career Start Year
2005
Number of shared co-authors
0
Henry Yang
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year
2005
Number of shared co-authors
0
Stefan Kubicek
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Career Start Year
2003
Number of shared co-authors
0
Andrew V Kossenkov
The Wistar Institute
Career Start Year
2003
Number of shared co-authors
0
Sabine Taschner-Mandl
St. Anna Children's Cancer Research Institute
Career Start Year
2002
Number of shared co-authors
0
Zhen Ye
Ludwig Institute for Cancer Research, University of California San Diego
Career Start Year
2002
Number of shared co-authors
0
Ernesto Guccione
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year
2001
Number of shared co-authors
0
David K Crossman
University of Alabama at Birmingham
Career Start Year
2000
Number of shared co-authors
0
Vivek Shukla
Chalmers University of Technology
Career Start Year
2000
Number of shared co-authors
2
Yan Liu
Chengdu Medical College
Career Start Year
1999
Number of shared co-authors
0
Clifton L Dalgard
Uniformed Services University of the Health Sciences
Career Start Year
1997
Number of shared co-authors
0
Dongquan Chen
University of Alabama at Birmingham
Career Start Year
1997
Number of shared co-authors
0
Lianbo Yu
The Ohio State University
Career Start Year
1997
Number of shared co-authors
0
Dirk Geerts
Amsterdam University Medical Center
Career Start Year
1989
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
M??nica Suelves
Germans Trias i Pujol Research Institute
Co-authored papers
6
Elvira Carri??
Swiss Tropical and Public Health Institute
Co-authored papers
2
David M Langenau
MGH Pathology and Harvard Medical School
Co-authored papers
1
Frank C Marini
Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine
Co-authored papers
1
Koichi Nishijo
Institute for Frontier Medical Sciences, Kyoto University
Co-authored papers
1
Simone Hettmer
University Medical Center Freiburg, University of Freiburg
Co-authored papers
1
Jaume Mora
Pediatric Cancer Center Barcelona, Hospital Sant Joan de Deu
Co-authored papers
1
Benjamin R Ehler
University of Texas Health Science Center at San Antonio
Co-authored papers
1
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
1
Christopher R R Bjornson
Stanford University School of Medicine
Co-authored papers
1
Amy J Wagers
Joslin Diabetes Center
Co-authored papers
1
John M Mariadason
Olivia Newton-John Cancer Research Institute
Co-authored papers
1
Andrew S Brack
University of California san francisco
Co-authored papers
1
Joel E Michalek
University of Texas Health Science Center
Co-authored papers
1
Atiya Mansoor
Oregon Health & Science University
Co-authored papers
1
Lee Ann Zarzabal
University of Texas Health Science Center
Co-authored papers
1
Bing-Hung Chen
Kaohsiung Medical University
Co-authored papers
1
Elaine Huang
Oregon Health and Science University, 3710 SW US Veterans Hospital Rd
Co-authored papers
1
Amanda T McCleish
Co-authored papers
1
Martin Goros
University of Texas Health San Antonio
Co-authored papers
1
Robin D LeGallo
University of Virginia Department of Pathology
Co-authored papers
1
Jinu Abraham
Oregon Health & Science University
Co-authored papers
1
Sheila T Hampton
Co-authored papers
1
Oscar M Tirado
Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)/CIBERONC
Co-authored papers
1
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers
1
Susan R Davis
Co-authored papers
1
Yidong Chen
Zhujiang Hospital, Southern Medical University
Co-authored papers
1
Jennifer Rebeles
Science Research Laboratories (SRL) 1.
Co-authored papers
1
Brian P Rubin
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
Co-authored papers
1
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
1
1 - 30